Management of dyskinesia in COMT-naive patients starting adjunctive therapy with opicapone: the BIPARK-I double-blind experience

被引：0
|
作者：
Pagonabarraga, J. [1 ]
Tolosa, E. [2 ]
Ferreira, J. [3 ]
Lees, A. [4 ]
Arbe, E. [5 ]
Rocha, J. [5 ]
Soares-Da-Silva, P. [6 ]
机构：
[1] Hosp Santa Creu & Sant Pau, Unit Movement Disorders, Neurol, Barcelona, Spain
[2] Hosp Clin Univ Barcelona, Parkinson Dis & Movement Disorder Unit, Barcelona, Spain
[3] Inst Med Mol, Neurol Clin Res Unit, Lisbon, Portugal
[4] Natl Hosp Neurol & Neurosurg, London, England
[5] BIAL Portela & Co SA, Global Parkinson Dis, Sao Mamede do Coronado, Portugal
[6] BIAL Portela & Co SA, Res & Dev, Sao Mamede do Coronado, Portugal
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2018年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPR3069
引用
收藏
页码：516 / 516
页数：1
相关论文
共 50 条
  • [41] Opicapone as First-Line Adjunctive Levodopa Treatment in Parkinson's Disease Patients with Motor Fluctuations: Findings from BIPARK-I and II Combined Post-Hoc Analysis
    Ferreira, J.
    Poewe, W.
    Antonini, A.
    Gama, H.
    Rocha, J. -F.
    Magalhaes, D.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2020, 35 : S447 - S448
  • [42] Opicapone's efficacy in Parkinson's disease patients with motor fluctuations: a phase III, randomized, double-blind, placebo and active-controlled study - bipark I study
    Ferreira, J.
    Lees, A.
    Rocha, I.
    Santos, A.
    Lopes, N.
    Soares-da-Silva, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E284 - E285
  • [43] Opicapone's added benefit as a first-line adjunctive therapy to levodopa and when used promptly in the motor fluctuations spectrum of Parkinson's disease: a post-hoc analysis of BIPARK-I and II
    Ebersbach, G.
    Ferreira, J.
    Antonini, A.
    Santos, A. -T.
    Magalhaes, D.
    Rocha, J-F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2020, 35 : S445 - S445
  • [44] Incidence of treatment-emergent adverse events in Parkinson's disease patients according to gender: post-hoc analysis from double-blind combined BIPARK-I and II data
    Ikedo, F.
    Ferreira, J.
    Lees, A.
    Tolosa, E.
    Poewe, W.
    Costa, R.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2019, 34 : S48 - S48
  • [45] Incidence of treatment-emergent adverse events in Parkinson's disease patients according to race: Post-hoc analysis from double-blind combined BIPARK-I and II data
    Costa, R.
    Lees, A.
    Ferreira, J.
    Rascol, O.
    Stocchi, F.
    Gama, H.
    Magalhaes, D.
    Rocha, F.
    Soares-da-Silva, P.
    Savic, N.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [46] Incidence of treatment-emergent adverse events in Parkinson's disease patients according to gender: Post-hoc analysis from double-blind combined BIPARK-I and II data
    Costa, R.
    Ferreira, J.
    Lees, A.
    Tolosa, E.
    Poewe, W.
    Ikedo, F.
    Magalhaes, D.
    Rocha, F.
    Soares-da-Silva, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [47] Incidence of treatment-emergent adverse events in Parkinson's disease patients according to race: post-hoc analysis from double-blind combined BIPARK-I and II data.
    Costa, R.
    Lees, A.
    Ferreira, J.
    Rascol, O.
    Stocchi, F.
    Gama, H.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2019, 34 : S37 - S37
  • [48] Incidence of treatment-emergent adverse events in Parkinson's disease patients according to baseline disease severity: Post-hoc analysis from double-blind combined BIPARK-I and II data
    Costa, R.
    Lees, A.
    Ferreira, J.
    Rascol, O.
    Stocchi, F.
    Gama, H.
    Magalhaes, D.
    Rocha, F.
    Soares-da-Silva, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [49] Incidence of treatment-emergent adverse events in Parkinson's disease patients according to baseline disease severity: post-hoc analysis from double-blind combined BIPARK-I and II data
    Costa, R.
    Lees, A.
    Ferreira, J.
    Rascol, O.
    Stocchi, F.
    Gama, H.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2019, 34 : S37 - S37
  • [50] A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ADJUNCTIVE NADOLOL IN THE MANAGEMENT OF VIOLENT PSYCHIATRIC-PATIENTS
    ALPERT, M
    ALLAN, ER
    CITROME, L
    LAURY, G
    SISON, C
    SUDILOVSKY, A
    PSYCHOPHARMACOLOGY BULLETIN, 1990, 26 (03) : 367 - 371
12345